# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 516 results.
IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
Status: Recruiting
Last Changed: Jan 31, 2020
First Received: Nov 08, 2013
Disease(s): Uterine Sarcoma
Intervention(s): Cabozantinib, Placebo
Locations: Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Institut Bergonie, Bordeaux, France
Centre Georges-Francois-Leclerc, Dijon, France
Centre Leon Berard, Lyon, France
Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Nantes, France
... and 7 other locations.
Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients
Status: Recruiting
Last Changed: Jul 09, 2019
First Received: Jan 24, 2019
Disease(s): Sarcoma, Soft Tissue
Intervention(s): anlotinib
Locations: Liaoning Province Tumor Hospital, Shenyang, Liaoning, China
Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
Status: Not yet recruiting
Last Changed: Jan 03, 2019
First Received: Jan 03, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Anlotinib
Locations: The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO™ Device in Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Feb 07, 2020
First Received: Feb 17, 2017
Disease(s): Soft Tissue Sarcoma Adult
Intervention(s): Multiple drug microinjection, CIVO device
Locations: Monter Cancer Center (Northwell Health), Lake Success, New York, United States
OHSU Knight Cancer Institute, Portland, Oregon, United States
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance (SCCA)/University of Washington, Seattle, Washington, United States
Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)
Status: Recruiting
Last Changed: Dec 26, 2018
First Received: Jul 17, 2017
Disease(s): Classic Kaposi Sarcoma
Intervention(s): Nivolumab, Ipilimumab
Locations: Rabin Medical Center, Petach Tikva, Israel
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Jul 22, 2019
Disease(s): Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma
Intervention(s): doxorubicin with AGEN1884 and AGEN2034
Locations: University of Colorado Hospital, Aurora, Colorado, United States
An Observational Study on Epithelioid Sarcoma
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Apr 04, 2017
Disease(s): Epithelioid Sarcoma
Intervention(s): Treatment for Epitheloid Sarcoma
Locations: Istituto Tumori Giovanni Paolo II, Bari, BA, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola, FC, Italy
Istituto Europeo di Oncologia, Milano, MI, Italy
Istituto Clinico Humanitas, Rozzano, MI, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
... and 11 other locations.
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
Status: Recruiting
Last Changed: Feb 06, 2020
First Received: Jun 03, 2016
Disease(s): Soft-tissue Sarcomas
Intervention(s): Procedure/Surgery
Locations: Institut Bergonié, Bordeaux, France
Centre Georges François Leclerc, Dijon Cedex, France
Centre Oscar Lambret, Lille Cedex, France
Centre Léon Bérard, Lyon Cedex 08, France
AP-HM _ Hôpital de la Timone, Marseille Cedex 05, France
... and 6 other locations.
MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Jul 14, 2017
Disease(s): Soft Tissue Sarcoma
Intervention(s): MDM2 Inhibitor AMG-232, Radiation Therapy
Locations: CTCA at Western Regional Medical Center, Goodyear, Arizona, United States
Mayo Clinic Hospital, Phoenix, Arizona, United States
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
... and 41 other locations.
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing Sarcoma
Status: Recruiting
Last Changed: Jan 31, 2020
First Received: Jul 26, 2018
Disease(s): Ewing Sarcoma
Intervention(s): SP-2577
Locations: Children's Hospital Los Angeles, Los Angeles, California, United States
Sarcoma Oncology Research Center, Santa Monica, California, United States
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
... and 4 other locations.